WFS1 and diabetes mellitus: Following CRISPR/Cas9 correction of WFS1 mutations in patients’ iPSCs, iPSC-beta cells showed dynamic glucose-stimulated insulin secretion and reversed pre-existing streptozotocin-induced diabetes after transplantation into mice [161].